Literature DB >> 22477553

Endometriosis causing lower extremity deep vein thrombosis - case report and review of the literature.

Rajinder P Sharma1, Fadi Delly, Horia Marin, Scott Sturza.   

Abstract

Endometriosis is a medical condition in women wherein endometrial cells deposited in the area outside the uterine cavity are influenced by hormonal changes, and produce symptoms depending on the site of implantation. A unique case of retroperitoneal endometriosis causing deep vein thrombosis from extrinsic compression of the right iliac vein is described. Clinical presentation with cyclical leg swelling, coincidental with menstruation and culminating with deep vein thrombosis, although very suggestive, has not been previously reported.

Entities:  

Year:  2009        PMID: 22477553      PMCID: PMC2903031          DOI: 10.1055/s-0031-1278354

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  34 in total

1.  Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study.

Authors:  A Fujishita; P K Nakane; T Koji; H Masuzaki; R O Chavez; T Yamabe; T Ishimaru
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

2.  Endometriosis in 1,000 consecutive celiotomies: incidence and management.

Authors:  T J Williams; J H Pratt
Journal:  Am J Obstet Gynecol       Date:  1977-10-01       Impact factor: 8.661

3.  The relation of endometriosis to menstrual characteristics, smoking, and exercise.

Authors:  D W Cramer; E Wilson; R J Stillman; M J Berger; S Belisle; I Schiff; B Albrecht; M Gibson; B V Stadel; S C Schoenbaum
Journal:  JAMA       Date:  1986-04-11       Impact factor: 56.272

4.  The unsuspected pelvic factor in the infertility investigation.

Authors:  T S Drake; G M Grunert
Journal:  Fertil Steril       Date:  1980-07       Impact factor: 7.329

5.  RU486-induced growth inhibition of human endometrial cells.

Authors:  A A Murphy; M H Zhou; S Malkapuram; N Santanam; S Parthasarathy; N Sidell
Journal:  Fertil Steril       Date:  2000-11       Impact factor: 7.329

6.  Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.

Authors:  J A Rock; J A Truglia; R J Caplan
Journal:  Obstet Gynecol       Date:  1993-08       Impact factor: 7.661

7.  Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up.

Authors:  K G Waller; R W Shaw
Journal:  Fertil Steril       Date:  1993-03       Impact factor: 7.329

8.  Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.

Authors:  Radhika K Ailawadi; Smeeta Jobanputra; Meera Kataria; Bilgin Gurates; Serdar E Bulun
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

9.  Repetitive conservative surgery for recurrence of endometriosis.

Authors:  G B Candiani; L Fedele; P Vercellini; S Bianchi; G Di Nola
Journal:  Obstet Gynecol       Date:  1991-03       Impact factor: 7.661

10.  Endometriosis causing cyclic compression of the right external iliac vein with cyclic edema of the right leg and thigh.

Authors:  Albert M Rosengarten; Joyce Wong; Sherry Gibbons
Journal:  J Obstet Gynaecol Can       Date:  2002-01
View more
  3 in total

1.  Endometriosis and cardiovascular disease.

Authors:  Benjamin Marchandot; Anais Curtiaud; Kensuke Matsushita; Antonin Trimaille; Aline Host; Emilie Faller; Olivier Garbin; Chérif Akladios; Laurence Jesel; Olivier Morel
Journal:  Eur Heart J Open       Date:  2022-02-02

2.  Chronic common femoral vein occlusion secondary to endometriosis.

Authors:  Mila H Ju; Mark L Keldahl; Heron E Rodriguez
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-10-01

3.  Thrombosis of iliac vessels, a rare complication of endometriosis: Case report and review of literature.

Authors:  Rita Chiaramonte; Salvatore Castorina; Emilio Giovanni Castorina; Alessandra Panarello; Salvatore Alessandro Maria Antoci
Journal:  J Adv Res       Date:  2016-11-01       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.